home / stock / xair / xair news


XAIR News and Press, Beyond Air Inc. From 08/10/23

Stock Information

Company Name: Beyond Air Inc.
Stock Symbol: XAIR
Market: NYSE
Website: beyondair.net

Menu

XAIR XAIR Quote XAIR Short XAIR News XAIR Articles XAIR Message Board
Get XAIR Alerts

News, Short Squeeze, Breakout and More Instantly...

XAIR - Beyond Air GAAP EPS of -$0.45 beats by $0.02

2023-08-10 16:18:43 ET Beyond Air press release ( NASDAQ: XAIR ): Q1 GAAP EPS of -$0.45 beats by $0.02 . As of June 30, 2023, the Company had cash, cash equivalents and marketable securities of $57.0 million and $2.7 million in restricted cash. For further detail...

XAIR - Beyond Air® Reports Financial Results for First Quarter of Fiscal Year 2024

GARDEN CITY, N.Y., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Reported commercial sales for LungFit® PH for the treatment of term and near-term neonates with hypoxic respiratory failure Currently have in excess of $1 million in annual commercial LungFit PH contracts Secured up to ...

XAIR - Beyond Air Q1 Earnings Preview

2023-08-09 17:35:11 ET Beyond Air ( NASDAQ: XAIR ) is scheduled to announce Q1 earnings results on Thursday, August 10th, after market close. The consensus EPS Estimate is -$0.47 and the consensus Revenue Estimate is $0.34M. For further details see: Beyond Air Q1...

XAIR - Beyond Air Inc. (NASDAQ: XAIR) Making Surprising Moves in Tuesday Session

Beyond Air, Inc. (NASDAQ: XAIR) has caught the attention of the investment community today with its bullish price action. The company's shares are currently up 10.25% on the day to $3.55. Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO...

XAIR - Beyond Air® Announces Positive Preclinical Data on Role of Nitric Oxide in Autism Spectrum Disorder (ASD)

Data to be presented at the 2023 International Society of Neurochemistry (ISN) and the European Society of Neurochemistry (ESN) meeting in Portugal Data provides further evidence that selective neuronal nitric oxide synthase (nNOS) inhibitors can play a role in the treatment of ASD ...

XAIR - Beyond Air® To Participate in BTIG's 2023 Virtual Biotechnology Conference

GARDEN CITY, N.Y., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”) a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to improve...

XAIR - Beyond Air ends selloff as Piper Sandler initiates at Overweight

2023-07-28 15:08:17 ET More on Beyond Air Beyond Air: Dilution Remains A Concern Beyond Air, Inc. ( XAIR ) Q4 2023 Earnings Call Transcript Beyond Air nears two-month high as BTIG starts at Buy Beyond Air ticks higher after insider purchases Seeki...

XAIR - XPEV, BILI, and FUTU are among pre market gainers

2023-07-28 08:23:12 ET Reata Pharmaceuticals ( RETA ) +51% agrees to buy Reata Pharmaceuticals in deal valued at $7.3B . SIGA Technologies ( SIGA ) +32% jumps 27% on U.S. government orders worth $138M. Coursera ( COUR ) +17% Q2 earnings call release INV...

XAIR - Beyond Air® Schedules First Fiscal Quarter 2024 Financial Results Conference Call and Webcast

GARDEN CITY, N.Y., July 24, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”) a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to improve...

XAIR - Wall Street Breakfast: The Week Ahead

2023-07-02 07:18:39 ET Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . For further details see: Wall Street Breakfast: The Week Ahead

Previous 10 Next 10